Literature DB >> 29087187

Application of the EF and GH Fragments to the Synthesis of Idraparinux.

Grzegorz Łopatkiewicz1, Szymon Buda1, Jacek Mlynarski1.   

Abstract

A novel total synthesis of fully protected idraparinux has been achieved. A short and efficient protocol for the synthesis of the EF fragment of idraparinux and its C5'-epi analogue (GH unit) has been developed. The same cellobiose unit was transformed in 14 steps into the fully protected EF and GH disaccharide fragments. The key step of this approach is an epimerization of C5 by an elimination-addition sequence leading to l-ido disaccharide (GH unit) with a total yield of 24% (36% for the EF fragment). 1,6-Anhydro ring opening gave suitable substrates for efficient synthesis of fully protected idraparinux. The fully protected antithrombotic pentasaccharide idraparinux was synthesized in 23 steps for the longest linear route, with a 1.7% overall yield from d-cellobiose and d-glucose.

Entities:  

Year:  2017        PMID: 29087187     DOI: 10.1021/acs.joc.7b02497

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  5 in total

1.  Synthesis of Four Orthogonally Protected Rare l-Hexose Thioglycosides from d-Mannose by C-5 and C-4 Epimerization.

Authors:  Fruzsina Demeter; Ilona Bereczki; Anikó Borbás; Mihály Herczeg
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

2.  Replacement of the L-iduronic acid unit of the anticoagulant pentasaccharide idraparinux by a 6-deoxy-L-talopyranose - Synthesis and conformational analysis.

Authors:  Fruzsina Demeter; Tamás Gyöngyösi; Zsuzsanna Bereczky; Katalin E Kövér; Mihály Herczeg; Anikó Borbás
Journal:  Sci Rep       Date:  2018-09-13       Impact factor: 4.379

3.  Programmable one-pot synthesis of heparin pentasaccharides enabling access to regiodefined sulfate derivatives.

Authors:  Supriya Dey; Chi-Huey Wong
Journal:  Chem Sci       Date:  2018-07-03       Impact factor: 9.825

Review 4.  Heparan Sulfate, Mucopolysaccharidosis IIIB and Sulfur Metabolism Disorders.

Authors:  Marta Kaczor-Kamińska; Kamil Kamiński; Maria Wróbel
Journal:  Antioxidants (Basel)       Date:  2022-03-30

5.  Carbohydrate-Based Chiral Iodoarene Catalysts: A Survey through the Development of an Improved Catalyst Design.

Authors:  Michael R Imrich; Linda E Biehler; Cäcilia Maichle-Mössmer; Thomas Ziegler
Journal:  Molecules       Date:  2019-10-28       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.